European Commission Approves Tablet Formulation of BeOne Medicines’ BRUKINSA® for All Approved Indications
Business Wire India BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the…
